Gilead Sciences, Inc. News Headlines

Get GILD Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Why You Shouldn't Bet Against Gilead Sciences (GILD) Stock - Tale of the Tape
11/25/2014 8:59:00 AM -

3 Biotech Growth Stocks You Can Buy Right Now
11/25/2014 8:17:02 AM - Motley Fool

AbbVie Takes Aim at Gilead Sciences
11/25/2014 8:01:04 AM - Motley Fool

Be Careful With Gilead - It May Be Time To Take Profits
11/25/2014 7:10:00 AM - Seeking Alpha

AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog
11/24/2014 7:00:00 PM -

Can Partnering To Fight Hepatitis C Pay At Enanta?
11/24/2014 4:44:00 PM - Investor's Business Daily

3 Biotech Stocks That Could Soar Even Higher
11/24/2014 3:44:02 PM - Motley Fool

Investors Should Be Concerned About Gilead
11/24/2014 1:37:00 PM - Seeking Alpha

Gilead Sciences Inc. Just Paid $125 Million for Something It Can't Use for a Year
11/24/2014 7:53:03 AM - Motley Fool

Get Your Wallet Out: Global Drug Spending is About to Hit a Dubious Milestone
11/23/2014 10:18:03 AM - Motley Fool

This May Be the Fastest Growing Big Biotech Stock Next Year (Hint: It's Not Gilead Sciences)
11/22/2014 1:47:02 PM - Motley Fool

This Time I Really Mean It
11/22/2014 10:30:00 AM - Seeking Alpha

Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog
11/20/2014 4:27:00 PM -

Notable ETF Inflow Detected - VTI, BAC, GILD, INTC
11/20/2014 11:14:34 AM - BNK Invest

Biotech's 3 Most Influential CEOs
11/20/2014 10:20:03 AM - Motley Fool

Nasdaq 100 Movers: TSLA, SPLS
11/19/2014 1:09:37 PM - BNK Invest

Gilead: Pipeline Now Includes Potential Renal Blockbuster
11/19/2014 11:35:00 AM - Seeking Alpha

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog
11/19/2014 11:23:00 AM -

Update: Gilead's Harvoni Receives Marketing Authorization In Europe
11/19/2014 11:17:00 AM - Seeking Alpha

Stock Market News for November 19, 2014 - Market News
11/19/2014 10:10:00 AM -

Gilead: Rising Net Income, Zero Debt And Strong R&D Pipeline
11/19/2014 7:45:00 AM - Seeking Alpha

Gilead's Value Without Its Hep C Franchise
11/18/2014 4:07:00 PM - Seeking Alpha

Buy Gilead Sciences Now At A Historic Low Valuation
11/18/2014 8:52:00 AM - Seeking Alpha

Dispelling Some Of The Myths Surrounding Gilead Sciences.
11/18/2014 8:22:00 AM - Seeking Alpha

Incyte Building Blockbuster Drug One Disease At A Time
11/17/2014 3:58:00 PM - Investor's Business Daily